Observational Study of Lenalidomide in Subjects With Mantle Cell Lymphoma Who Failed Ibrutinib Treatment
NCT02341781
·
clinicaltrials.gov ↗
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Lymphoma, Mantle-Cell
Sponsor
Celgene